Hepatoprotection food composition and pharmaceutical composition with strains of lactic acid bacteria
AssigneeGlac Biotech Co., Ltd.
InventorsHsieh-Hsun HO, Yi Wei KUO, Jui- Fen CHEN, Ching-Wei CHEN
Life of this patent
Estimating the term…
Abstract
At least one isolated lactic acid bacteria strains selected from the following: TSP05 (Lactobacillus plantarum), TSF331 (Lactobacillus fermentum) and TSR332 (Lactobacillus reuteri) is provided. The above-mentioned active or inactive lactic acid bacteria strains have a function of hepatoprotection and is used in a form of a food composition or a pharmaceutical composition.
Claims23
A composition with lactic acid bacteria strains, comprising:
- at least one lactic acid bacteria strain able to prevent livers from damage caused by oxidative stress, wherein the lactic acid bacteria strain comprises at least one isolated lactic acid bacteria strain of a TSP05 strain of Lactobacillus plantarum with a deposition number of CGMCC No. 16710, a TSF331 strain of Lactobacillus fermentum with a deposition number of CGMCC No. 15527, and a TSR332 strain of Lactobacillus reuteri with a deposition number of CGMCC No. 15528, and wherein the lactic acid bacteria strains are deposited in China General Microbiological Culture Collection Center (CGMCC);
- and
- a physiologically or pharmaceutically-acceptable excipient, diluent or carrier.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for preventing livers from damage caused by oxidative stress, comprising administering a composition with lactic acid bacteria strains to a subject, wherein the composition comprises:
- at least one lactic acid bacteria strain able to prevent livers from damage caused by oxidative stress, wherein the lactic acid bacteria strain comprises at least one isolated lactic acid bacteria strain of a TSP05 strain of Lactobacillus plantarum with a deposition number of CGMCC No. 16710, a TSF331 strain of Lactobacillus fermentum with a deposition number of CGMCC No. 15527, and a TSR332 strain of Lactobacillus reuteri with a deposition number of CGMCC No. 15528, wherein the lactic acid bacteria strains are deposited in China General Microbiological Culture Collection Center (CGMCC);
- and
- a physiologically or pharmaceutically-acceptable excipient, diluent or carrier.
Dependencies are inferred from the claim text.